IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

CAG Income from Operations

CAG Income from Operations % Chg.

CAG Income from Operations Common Size

Water Income from Operations

Water Income from Operations % Chg.

Water Income from Operations Common Size

LPD Income from Operations

LPD Income from Operations % Chg.

LPD Income from Operations Common Size

Other Income from Operations

Other Income from Operations % Chg.

Other Income from Operations Common Size

Other EBIT

Other EBIT % Chg.

Other EBIT Common Size

Total EBIT

Total EBIT Common Size

Total EBIT % Chg.

Catalyst Installed Base (Units)

Catalyst Installed Base (Units) % Chg.

Premium Hermatology Installed Base (Units)

Premium Hermatology Installed Base (Units) % Chg.

SediVue Installed Base (Units)

SediVue Installed Base (Units) % Chg.

Key Performance Indicators

IDEXX VetLab Consumables Revenue

IDEXX VetLab Consumables Revenue % Chg.

IDEXX VetLab Consumables Revenue Common Size

Rapid Assay Products Revenue

Rapid Assay Products Revenue % Chg.

Rapid Assay Products Revenue Common Size

Reference Laboratory Diagnostic & Consulting Revenue

Reference Laboratory Diagnostic & Consulting Revenue % Chg.

Reference Laboratory Diagnostic & Consulting Revenue Common Size

CAG Diagnostics Services & Accessories Revenue

CAG Diagnostics Services & Accessories Revenue % Chg.

CAG Diagnostics Services & Accessories Revenue Common Size

CAG Diagnostics Recurring Revenue

CAG Diagnostics Recurring Revenue % Chg.

CAG Diagnostics Recurring Revenue Common Size

CAG Diagnostics Capital - Instruments Revenue

CAG Diagnostics Capital - Instruments Revenue % Chg.

CAG Diagnostics Capital - Instruments Revenue Common Size

Veterinary Software, Services & Diagnostics Revenue

Veterinary Software, Services & Diagnostics Revenue % Chg.

Veterinary Software, Services & Diagnostics Revenue Common Size

CAG Total Revenue

CAG Total Revenue % Chg.

CAG Total Revenue Common Size

Water Segment Revenue

Water Segment Revenue % Chg.

Water Segment Revenue Common Size

LPD Segment Revenue

LPD Segment Revenue % Chg.

LPD Segment Revenue Common Size

Other Revenue

Other Revenue % Chg.

Other Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	LTM	Dec '24	Dec '23
IDEXX VetLab Consumables Revenue	1,439.5	1,303.3	1,188.3
Rapid Assay Products Revenue	350.3	359.8	344.5
Reference Laboratory Diagnostic & Consulting Revenue	1,390.9	1,336.1	1,278.6
CAG Diagnostics Services & Accessories Revenue	134.3	130.4	124.1
CAG Diagnostics Recurring Revenue	3,315	3,129.5	2,935.4
CAG Diagnostics Capital - Instruments Revenue	175.1	131.9	137.6
Veterinary Software, Services & Diagnostics Revenue	335.2	312.6	279.3
CAG Total Revenue	3,825.3	3,574	3,352.4
Water Segment Revenue	195.8	185.1	168.1
LPD Segment Revenue	128.9	122.1	121.7
Other Revenue	17.5	16.3	18.8
Other Revenue	—	—	—
Total Revenue	4,167.4	3,897.5	3,661

EBIT	LTM	Dec '24	Dec '23
CAG Income from Operations	1,212.2	1,038.4	1,012.7
Water Income from Operations	92.9	84.5	74.3
LPD Income from Operations	3.5	6.6	10
Other Income from Operations	-2.4	-1.2	0.1
Other EBIT	—	—	—
Total EBIT	1,306.1	1,128.3	1,097.1

Key Performance Indicators	LTM	Dec '24	Dec '23
Catalyst Installed Base (Units)	0.1	0.1	0.1
Premium Hermatology Installed Base (Units)	0.1	0.1	0
SediVue Installed Base (Units)	0	0	0